亚裔美国男性MRI-超声融合靶向活检结局差异:多中心研究
该多中心前瞻性队列纳入2571例因PSA升高行MRI靶向联合系统活检的男性,其中亚裔美国男性275例(11%)。亚裔美国男性临床显著前列腺癌(GG≥2)检出率37%低于其他种族48%(p<0.001),GG1检出率亦更低(12% vs 18%,p=0.007)。校正分析显示亚裔美国男性显著癌检出风险更低(OR 0.57,95%CI 0.42-0.79,p<0.001)。
要点
- 亚裔美国男性靶向活检显著前列腺癌检出率低于其他种族(37% vs 48%)。
- PI-RADS 3病灶在亚裔美国男性中显著癌检出率更低(12% vs 21%)。
- 选择亚裔美国男性活检时需调整传统风险评估工具。
核心结论
- 亚裔美国男性靶向活检临床显著前列腺癌检出率更低,提示PI-RADS在该人群性能不同。
研究设计与样本
- 多中心前瞻性队列纳入2571例因PSA升高行MRI靶向联合系统活检的男性,其中亚裔美国男性275例(11%)。
主要发现
- 亚裔美国男性临床显著前列腺癌(GG≥2)检出率37%,其他种族48%(p<0.001)。
- 亚裔美国男性GG1癌检出率12%,其他种族18%(p=0.007)。
- PI-RADS 3病灶显著癌检出率亚裔美国男性12%,其他种族21%(p=0.032)。
- 校正分析亚裔美国男性显著癌检出OR 0.57(95%CI 0.42-0.79,p<0.001)。
- 校正分析亚裔美国男性GG1癌检出OR 0.57(95%CI 0.38-0.84,p=0.005)。
临床怎么用
- 针对亚裔美国男性选择活检时,应考虑调整传统风险评估工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Asian American men have distinctly different prostate cancer epidemiology than other men. To our knowledge the role of multiparametric magnetic resonance imaging and targeted biopsy for elevated prostate specific antigen in this population has not been assessed. We sought to define imaging and targeted biopsy outcomes in Asian American men compared to other men. MATERIALS AND METHODS: We accrued a multicenter, prospective cohort of men who underwent magnetic resonance imaging targeted and systematic biopsy for elevated prostate specific antigen. The outcome of interest was a diagnosis of clinically significant prostate cancer (Gleason Grade Group 2 or greater) stratified by the PI-RADS™ (Prostate Imaging-Reporting and Data System) score and a history of negative biopsy. Multivariable logistic regression was used to assess the effect of Asian American race on cancer detection. RESULTS: Of the 2,571 men 275 (11%) were Asian American. Clinically significant prostate cancer was detected in 37% of Asian American men compared to 48% of men of other races (p <0.001). Asian American men were also less likely to be diagnosed with Grade Group 1 cancer (12% vs 18%, p=0.007). Additionally, there was significantly lower detection of significant cancer using PI-RADS 3 in Asian American men vs men of other races (12% vs 21%, p=0.032). On adjusted analysis Asian American men were less likely to be diagnosed with significant cancer (OR 0.57, 95% CI 0.42-0.79, p <0.001) and Grade Group 1 cancer (OR 0.57, 95% CI 0.38-0.84, p=0.005) than nonAsian men. CONCLUSIONS: Asian American men are less likely to be diagnosed with clinically significant prostate cancer on targeted biopsy, illustrating the different performance of PI-RADS in this population. Conventional risk assessment tools should be modified when selecting Asian American men for biopsy.
引用
- Gross MD, Marks LS, Sonn GA, et al. Variation in Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy Outcomes in Asian American Men: A Multicenter Study. J Urol. 2019. PMID: 31502942. doi:10.1097/JU.0000000000000534
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。